Clinical ineffectiveness of IL-2 and/or IFNŕ administra==tion after autologous PBSC transplantation in pediatric oncological patients

0191171 - UMG-J 20010240 RIV GB eng J - Článek v odborném periodiku
Vlk, V. - Eckschlager, T. - Kavan, P. - Kabíčková, E. - Koutecký, J. - Sobota, Vesna - Bubeník, Jan - Pospíšilová, D.
Clinical ineffectiveness of IL-2 and/or IFNŕ administra==tion after autologous PBSC transplantation in pediatric oncological patients.
Pediatric Hematology and Oncology. Roč. 17, č. 1 (2000), s. 31-44. ISSN 0888-0018. E-ISSN 1521-0669
Grant CEP: GA MZd NC5526
Kód oboru RIV: EB - Genetika a molekulární biologie
Impakt faktor: 0.601, rok: 2000

Clinical impact of sc administration of IL-2 and/or IFNŕ was studied in pediatric patients with Hodgkin lymphoma and sarcoma, non-Hodgkin lymphoma, peripheral neuroepithelioma, neuroblastoma, and embryonic carcinoma after autologous PBSC transplantation. T and NK cell proliferation and induction of surface adctivation markers were followed. No significant clinical benefit of the immunotherapy was observed.
Trvalý link: http://hdl.handle.net/11104/0086928